Abbott Reports First Global Procedure in the Study of Volt Pulsed Field Ablation System for Abnormal Heart Rhythms
Shots:
- Abbott has conducted the first global procedure using the Volt Pulsed Field Ablation (PFA) System for treating abnormal heart rhythms like atrial fibrillation (AFib). It also treated 30 patients under (Volt CE Mark) study, aimed at assessing the safety and efficacy of the Volt PFA System, in Australia
- The Volt PFA System combines the balloon-in-basket catheter with the EnSite X EP System to improve accuracy in ablation procedures for better contact with targeted heart tissue while the balloon transfers energy efficiently to enhance the creation of lesions for stopping erratic heart signals
- Additionally, the company expects to secure approval for the US clinical study (IDE) to evaluate the Volt PFA System in the H1’24
Ref: Abbott | Image: Abbott
Related News:- Abbott Reports Real-World Study Results for its Healthy Food Rx Program as a Treatment for Diabetes
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
